{"success":true,"data":{"pressRelease":{"id":"3938","rtpr_id":"nACSlsFnza","ticker":"BSX","exchange":"NYSE","all_tickers":["BSX"],"title":"BSX DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - BSX","author":"ACCESSWIRE","published_at":"2026-04-22T03:01:00.472Z","article_body":"NEW YORK, NY / ACCESS Newswire (https://www.accessnewswire.com/) / April 21,\n2026 / WHY: New York, N.Y., April 21, 2026. Rosen Law Firm, a global investor\nrights law firm, reminds purchasers of common stock of Boston Scientific\nCorporation (NYSE:BSX) between July 23, 2025 and February 3, 2026, inclusive\n(the \"Class Period\"), of the important May 4, 2026 lead plaintiff deadline.\n(https://app.accessnewswire.com/imagelibrary/b1ba4543-0cf8-4724-9bea-79fa52e633de/1159832/image.png)\nSO WHAT: If you purchased Boston Scientific common stock during the Class\nPeriod you may be entitled to compensation without payment of any out of\npocket fees or costs through a contingency fee arrangement.\n\nWHAT TO DO NEXT: To join the Boston Scientific class action, go to\nhttps://rosenlegal.com/submit-form/?case_id=55398 or call Phillip Kim, Esq.\ntoll-free at 866-767-3653 or email case@rosenlegal.com for information on the\nclass action. A class action lawsuit has already been filed. If you wish to\nserve as lead plaintiff, you must move the Court no later than May 4, 2026. A\nlead plaintiff is a representative party acting on behalf of other class\nmembers in directing the litigation.\n\nWHY ROSEN LAW: We encourage investors to select qualified counsel with a track\nrecord of success in leadership roles. Often, firms issuing notices do not\nhave comparable experience, resources, or any meaningful peer recognition.\nMany of these firms do not actually handle securities class actions, but are\nmerely middlemen that refer clients or partner with law firms that actually\nlitigate the cases. Be wise in selecting counsel. The Rosen Law Firm\nrepresents investors throughout the globe, concentrating its practice in\nsecurities class actions and shareholder derivative litigation. Rosen Law Firm\nhas achieved, at that time, the largest ever securities class action\nsettlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS\nSecurities Class Action Services for number of securities class action\nsettlements in 2017. The firm has been ranked in the top 4 each year since\n2013 and has recovered hundreds of millions of dollars for investors. In 2019\nalone the firm secured over $438 million for investors. In 2020, founding\npartner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many\nof the firm's attorneys have been recognized by Lawdragon and Super Lawyers.\n\nDETAILS OF THE CASE: According to the lawsuit, during the Class Period,\ndefendants made positive statements to investors while, at the same time,\ndisseminating materially false and misleading statements and/or concealing\nmaterial adverse facts concerning the true state of Boston Scientific's U.S.\nElectrophysiology segment; notably, that management was aware that the\nsegment's growth rate was unsustainable and that it was approaching an earlier\ntipping point than the market was anticipating. Due to defendants' statements\nof confidence and lofty expectations, investors and analysts were left\nsurprised by Boston Scientific's net income miss and underwhelming guidance\nfor the first half of fiscal 2026. When the true details entered the market,\nthe lawsuit claims that investors suffered damages.\n\nTo join the Boston Scientific class action, go to\nhttps://rosenlegal.com/submit-form/?case_id=55398 or call Phillip Kim, Esq.\ntoll-free at 866-767-3653 or email case@rosenlegal.com for information on the\nclass action.\n\nNo Class Has Been Certified. Until a class is certified, you are not\nrepresented by counsel unless you retain one. You may select counsel of your\nchoice. You may also remain an absent class member and do nothing at this\npoint. An investor's ability to share in any potential future recovery is not\ndependent upon serving as lead plaintiff.\n\nFollow us for updates on LinkedIn:\nhttps://www.linkedin.com/company/the-rosen-law-firm, on Twitter:\nhttps://twitter.com/rosen_firm or on Facebook:\nhttps://www.facebook.com/rosenlawfirm/.\n\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n\n-------------------------------\n\nContact Information:\n\nLaurence Rosen, Esq.\nPhillip Kim, Esq.\nThe Rosen Law Firm, P.A.\n275 Madison Avenue, 40th Floor\nNew York, NY 10016\nTel: (212) 686-1060\nToll Free: (866) 767-3653\nFax: (212) 202-3827\ncase@rosenlegal.com\nwww.rosenlegal.com\n\nSOURCE: The Rosen Law Firm, P.A.\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bsx-deadline-rosen-top-ranked-investor-counsel-encourages-boston-1159832)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nACSlsFnza","title":"BSX DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - BSX","author":"ACCESSWIRE","ticker":"BSX","created":"2026-04-22T03:01:00.472Z","tickers":["BSX"],"exchange":"NYSE","article_body":"NEW YORK, NY / ACCESS Newswire (https://www.accessnewswire.com/) / April 21,\n2026 / WHY: New York, N.Y., April 21, 2026. Rosen Law Firm, a global investor\nrights law firm, reminds purchasers of common stock of Boston Scientific\nCorporation (NYSE:BSX) between July 23, 2025 and February 3, 2026, inclusive\n(the \"Class Period\"), of the important May 4, 2026 lead plaintiff deadline.\n(https://app.accessnewswire.com/imagelibrary/b1ba4543-0cf8-4724-9bea-79fa52e633de/1159832/image.png)\nSO WHAT: If you purchased Boston Scientific common stock during the Class\nPeriod you may be entitled to compensation without payment of any out of\npocket fees or costs through a contingency fee arrangement.\n\nWHAT TO DO NEXT: To join the Boston Scientific class action, go to\nhttps://rosenlegal.com/submit-form/?case_id=55398 or call Phillip Kim, Esq.\ntoll-free at 866-767-3653 or email case@rosenlegal.com for information on the\nclass action. A class action lawsuit has already been filed. If you wish to\nserve as lead plaintiff, you must move the Court no later than May 4, 2026. A\nlead plaintiff is a representative party acting on behalf of other class\nmembers in directing the litigation.\n\nWHY ROSEN LAW: We encourage investors to select qualified counsel with a track\nrecord of success in leadership roles. Often, firms issuing notices do not\nhave comparable experience, resources, or any meaningful peer recognition.\nMany of these firms do not actually handle securities class actions, but are\nmerely middlemen that refer clients or partner with law firms that actually\nlitigate the cases. Be wise in selecting counsel. The Rosen Law Firm\nrepresents investors throughout the globe, concentrating its practice in\nsecurities class actions and shareholder derivative litigation. Rosen Law Firm\nhas achieved, at that time, the largest ever securities class action\nsettlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS\nSecurities Class Action Services for number of securities class action\nsettlements in 2017. The firm has been ranked in the top 4 each year since\n2013 and has recovered hundreds of millions of dollars for investors. In 2019\nalone the firm secured over $438 million for investors. In 2020, founding\npartner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many\nof the firm's attorneys have been recognized by Lawdragon and Super Lawyers.\n\nDETAILS OF THE CASE: According to the lawsuit, during the Class Period,\ndefendants made positive statements to investors while, at the same time,\ndisseminating materially false and misleading statements and/or concealing\nmaterial adverse facts concerning the true state of Boston Scientific's U.S.\nElectrophysiology segment; notably, that management was aware that the\nsegment's growth rate was unsustainable and that it was approaching an earlier\ntipping point than the market was anticipating. Due to defendants' statements\nof confidence and lofty expectations, investors and analysts were left\nsurprised by Boston Scientific's net income miss and underwhelming guidance\nfor the first half of fiscal 2026. When the true details entered the market,\nthe lawsuit claims that investors suffered damages.\n\nTo join the Boston Scientific class action, go to\nhttps://rosenlegal.com/submit-form/?case_id=55398 or call Phillip Kim, Esq.\ntoll-free at 866-767-3653 or email case@rosenlegal.com for information on the\nclass action.\n\nNo Class Has Been Certified. Until a class is certified, you are not\nrepresented by counsel unless you retain one. You may select counsel of your\nchoice. You may also remain an absent class member and do nothing at this\npoint. An investor's ability to share in any potential future recovery is not\ndependent upon serving as lead plaintiff.\n\nFollow us for updates on LinkedIn:\nhttps://www.linkedin.com/company/the-rosen-law-firm, on Twitter:\nhttps://twitter.com/rosen_firm or on Facebook:\nhttps://www.facebook.com/rosenlawfirm/.\n\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n\n-------------------------------\n\nContact Information:\n\nLaurence Rosen, Esq.\nPhillip Kim, Esq.\nThe Rosen Law Firm, P.A.\n275 Madison Avenue, 40th Floor\nNew York, NY 10016\nTel: (212) 686-1060\nToll Free: (866) 767-3653\nFax: (212) 202-3827\ncase@rosenlegal.com\nwww.rosenlegal.com\n\nSOURCE: The Rosen Law Firm, P.A.\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bsx-deadline-rosen-top-ranked-investor-counsel-encourages-boston-1159832)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved."},"type":"article","timestamp":"2026-04-22T03:01:00.519045973Z","server_sent_at_ms":1776826860519},"received_at":"2026-04-22T03:01:00.570Z","source_url":"https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bsx-deadline-rosen-top-ranked-investor-counsel-encourages-boston-1159832"},"analysis":{"id":"2741","press_release_id":"3938","analysis_json":{"industry":{"label":"Health Care Equipment & Services","sector":"Health Care"},"redFlags":["Allegations that management concealed unsustainability of U.S. Electrophysiology segment growth","Securities fraud lawsuit cites subsequent net income miss and weak guidance as consequence of alleged misstatements"],"eventType":"legal_litigation","narrative":"Rosen Law Firm announced a May 4, 2026 lead plaintiff deadline for a class action involving Boston Scientific investors who purchased stock between July 23, 2025 and February 3, 2026.\n\nThe lawsuit alleges that defendants made materially false statements about the U.S. Electrophysiology segment, specifically claiming management concealed that its growth rate was unsustainable and approaching a tipping point earlier than expected.\n\nThese alleged misrepresentations purportedly left investors surprised by a net income miss and underwhelming guidance for the first half of fiscal 2026, causing damages when the actual details emerged.","sentiment":"bearish","agentHooks":{"shouldPost":true,"suggestedAngle":"BSX targeted in class action alleging deceptive practices regarding Electrophysiology growth trajectory."},"keyFigures":{"customDimensions":{"class_period_end":"February 3, 2026","class_period_start":"July 23, 2025","lead_plaintiff_deadline":"May 4, 2026"}},"quotedText":"management was aware that the segment's growth rate was unsustainable and that it was approaching an earlier tipping point than the market was anticipating","namedEntities":{"people":[{"name":"Laurence Rosen","role":"Founding Partner"},{"name":"Phillip Kim","role":"Contact"}],"products":[],"companies":[{"name":"Boston Scientific Corporation","ticker":"BSX"},{"name":"Rosen Law Firm, P.A.","relationship":"plaintiff counsel"}],"dollarAmounts":[{"amount":"$438 million","context":"securities class action settlements secured by Rosen Law Firm in 2019"},{"amount":"hundreds of millions of dollars","context":"total recovered for investors by Rosen Law Firm"}]},"materialImpact":{"score":4,"reasoning":"The filing of a securities class action alleging materially false and misleading statements regarding a core business segment's growth and subsequent guidance cuts constitutes a significant legal and reputational risk."},"tickerRelevance":{"others":[],"primary":"BSX"},"eventTypeSecondary":[]},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"bearish","material_impact_score":4,"narrative":"Rosen Law Firm announced a May 4, 2026 lead plaintiff deadline for a class action involving Boston Scientific investors who purchased stock between July 23, 2025 and February 3, 2026.\n\nThe lawsuit alleges that defendants made materially false statements about the U.S. Electrophysiology segment, specifically claiming management concealed that its growth rate was unsustainable and approaching a tipping point earlier than expected.\n\nThese alleged misrepresentations purportedly left investors surprised by a net income miss and underwhelming guidance for the first half of fiscal 2026, causing damages when the actual details emerged.","key_figures":{"customDimensions":{"class_period_end":"February 3, 2026","class_period_start":"July 23, 2025","lead_plaintiff_deadline":"May 4, 2026"}},"named_entities":{"people":[{"name":"Laurence Rosen","role":"Founding Partner"},{"name":"Phillip Kim","role":"Contact"}],"products":[],"companies":[{"name":"Boston Scientific Corporation","ticker":"BSX"},{"name":"Rosen Law Firm, P.A.","relationship":"plaintiff counsel"}],"dollarAmounts":[{"amount":"$438 million","context":"securities class action settlements secured by Rosen Law Firm in 2019"},{"amount":"hundreds of millions of dollars","context":"total recovered for investors by Rosen Law Firm"}]},"model_name":"glm-4.7","prompt_hash":"sha256:2f2748f0fcc8c4f2","schema_hash":"sha256:ad96b863d7123008","created_at":"2026-04-22T04:29:05.070Z","global_importance":3,"audience_relevance":3,"importance_components":{"method":"backfill-heuristic","signals":{"bodyLong":false,"headlineTier1":false,"tickerCovered":false,"hadSignificance":false},"version":1,"computedAt":"2026-04-27T11:52:53.843Z"}},"durationMs":99918,"modelName":"glm-4.7"}}